[
  {
    "ts": null,
    "headline": "The weight-loss frenzy is making some pharma stocks much more volatile. Will the drama continue?",
    "summary": "The excitement around the new weight-loss industry is overtaking other disease areas and portfolios for publicly traded companies.",
    "url": "https://finnhub.io/api/news?id=123d0bbd8fcfa38ae969f58b412123706f312a0a34444ac3d2cd0d7dd24e8ace",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731765632,
      "headline": "The weight-loss frenzy is making some pharma stocks much more volatile. Will the drama continue?",
      "id": 131393742,
      "image": "",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "The excitement around the new weight-loss industry is overtaking other disease areas and portfolios for publicly traded companies.",
      "url": "https://finnhub.io/api/news?id=123d0bbd8fcfa38ae969f58b412123706f312a0a34444ac3d2cd0d7dd24e8ace"
    }
  },
  {
    "ts": null,
    "headline": "2 Reasons to Buy Amgen Stock, and 1 Reason to Be Cautious",
    "summary": "Its future is bright, but that doesn't mean it'll always be smooth sailing.",
    "url": "https://finnhub.io/api/news?id=0c40ed5127b620668170393eb8850ede0c8b494ece6b4e262a827e3b94b26c95",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731764700,
      "headline": "2 Reasons to Buy Amgen Stock, and 1 Reason to Be Cautious",
      "id": 131394864,
      "image": "https://g.foolcdn.com/editorial/images/797556/scientist-examines-samples-with-microscope-while-in-laboratory.jpg",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Its future is bright, but that doesn't mean it'll always be smooth sailing.",
      "url": "https://finnhub.io/api/news?id=0c40ed5127b620668170393eb8850ede0c8b494ece6b4e262a827e3b94b26c95"
    }
  },
  {
    "ts": null,
    "headline": "The three-year decline in earnings for Amgen NASDAQ:AMGN) isn't encouraging, but shareholders are still up 50% over that period",
    "summary": "Amgen Inc. ( NASDAQ:AMGN ) shareholders might be concerned after seeing the share price drop 13% in the last week. But...",
    "url": "https://finnhub.io/api/news?id=632033c59177e1b727ea426a160a88ac56b9f235c8584a4095fad3a3e5f4057a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731754830,
      "headline": "The three-year decline in earnings for Amgen NASDAQ:AMGN) isn't encouraging, but shareholders are still up 50% over that period",
      "id": 131394865,
      "image": "https://media.zenfs.com/en/simply_wall_st__316/7137ef364be97d9882cfa4ec57169a99",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amgen Inc. ( NASDAQ:AMGN ) shareholders might be concerned after seeing the share price drop 13% in the last week. But...",
      "url": "https://finnhub.io/api/news?id=632033c59177e1b727ea426a160a88ac56b9f235c8584a4095fad3a3e5f4057a"
    }
  }
]